Loading...

Home
ETF
ELDN

ELDN

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ELDN News

Eledon Pharmaceuticals Presents 24-Month Data on Tegoprubart, Showing Significant eGFR Improvement

Jan 23 2026Newsfilter

Avant Technologies Achieves 83% Insulin Independence Rate, Driving Investment Shift

Dec 31 2025PRnewswire

Avant Technologies Achieves 83% Insulin Independence Rate, Driving Metabolic Disease Investment

Dec 31 2025Newsfilter

Biotech Sector Sustains After-Hours Trading Gains

Dec 18 2025NASDAQ.COM

Eledon Pharmaceuticals Reports GAAP EPS of -$0.21

Nov 14 2025SeekingAlpha

Eledon Pharmaceuticals' Key Asset Falls Short in Mid-Stage Trial, Yet Advances to Crucial Study

Nov 07 2025Benzinga

Dow Falls More Than 200 Points; Fluor Stock Declines Following Q3 Earnings Report

Nov 07 2025Benzinga

What Caused Eledon Pharmaceuticals Stock (ELDN) to Drop 50% Today?

Nov 07 2025TipRanks

Eledon to Progress Kidney Transplant Rejection Treatment to Phase 3 Despite Phase 2 Setback on Key Objective

Nov 07 2025NASDAQ.COM

Eledon Unveils Phase 2 BESTOW Trial Findings for Tegoprubart Aimed at Preventing Kidney Transplant Rejection at the 2025 American Society of Nephrology Kidney Week Annual Meeting

Nov 06 2025Newsfilter

Putting the Pieces Together: VTWO May Be Valued at $112

Aug 25 2025NASDAQ.COM

New Strong Buy Stocks for July 14th

Jul 14 2025NASDAQ.COM

Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

Jul 09 2025Globenewswire

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

Jun 25 2025Newsfilter

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Arcutis Biotherapeutics (ARQT)

Mar 24 2025Business Insider

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

Mar 04 2025Newsfilter